(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1606566 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BACE1 mRNA CTD PMID:22079256 (25R)-cholest-5-ene-3beta,26-diol increases expression ISO RGD:1606566 6480464 27-hydroxycholesterol results in increased expression of BACE1 protein CTD PMID:19126211 (R,R,R)-alpha-tocopherol multiple interactions ISO RGD:1606566 6480464 alpha-Tocopherol inhibits the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA] CTD PMID:19196431 (S)-naringenin decreases activity ISO RGD:1606566 6480464 naringenin results in decreased activity of BACE1 protein CTD PMID:31194956 1,1-dichloroethene increases expression ISO RGD:1332039 6480464 vinylidene chloride results in increased expression of BACE1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:1332039 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BACE1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of BACE1 mRNA CTD PMID:29097150 2,2,2-tetramine multiple interactions ISO RGD:1606566 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [Trientine inhibits the reaction [S100B protein results in increased expression of BACE1 protein]], Trientine inhibits the reaction [S100B protein results in increased expression of BACE1 protein] CTD PMID:23541064 2,2,2-tetramine decreases expression ISO RGD:1332039 6480464 Trientine results in decreased expression of BACE1 protein CTD PMID:23541064 2,2,2-tetramine decreases expression ISO RGD:1606566 6480464 Trientine results in decreased expression of BACE1 protein CTD PMID:23541064 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1332039 6480464 Tetrachlorodibenzodioxin affects the expression of BACE1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BACE1 mRNA CTD PMID:33387578 26-hydroxycholesterol increases expression ISO RGD:1606566 6480464 27-hydroxycholesterol results in increased expression of BACE1 protein CTD PMID:19126211 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1332039 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of BACE1 mRNA CTD PMID:20188158 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BACE1 mRNA CTD PMID:36041667 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of BACE1 mRNA CTD PMID:24780913 acrolein increases expression ISO RGD:1332039 6480464 Acrolein results in increased expression of BACE1 protein CTD PMID:23296102 acrolein increases expression EXP 6480464 Acrolein results in increased expression of BACE1 protein CTD PMID:23296102 , PMID:29355571 aflatoxin B1 increases expression ISO RGD:1332039 6480464 Aflatoxin B1 results in increased expression of BACE1 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1606566 6480464 Aflatoxin B1 results in increased methylation of BACE1 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1606566 6480464 Aflatoxin B1 results in decreased expression of BACE1 mRNA CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1606566 6480464 Aflatoxin B1 results in increased expression of BACE1 mRNA CTD PMID:21641981 alendronic acid multiple interactions ISO RGD:1332039 6480464 Alendronate inhibits the reaction [Streptozocin results in increased expression of BACE1 protein] CTD PMID:30481507 all-trans-retinoic acid affects localization ISO RGD:1606566 6480464 Tretinoin affects the localization of BACE1 protein CTD PMID:19476501 all-trans-retinoic acid decreases expression ISO RGD:1606566 6480464 Tretinoin results in decreased expression of BACE1 mRNA CTD PMID:33167477 all-trans-retinoic acid increases expression ISO RGD:1606566 6480464 Tretinoin results in increased expression of BACE1 mRNA, Tretinoin results in increased expression of BACE1 protein CTD PMID:16279945 more ... all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin inhibits the reaction [Vitamin A affects the expression of BACE mRNA] CTD PMID:16530976 all-trans-retinoic acid increases expression ISO RGD:1332039 6480464 Tretinoin results in increased expression of BACE1 mRNA, Tretinoin results in increased expression of BACE1 protein CTD PMID:19476501 all-trans-retinol multiple interactions EXP 6480464 Tretinoin inhibits the reaction [Vitamin A affects the expression of BACE mRNA] CTD PMID:16530976 all-trans-retinol affects expression EXP 6480464 Vitamin A affects the expression of BACE mRNA CTD PMID:16530976 aminoguanidine multiple interactions ISO RGD:1606566 6480464 pimagedine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BACE1 mRNA] CTD PMID:28242320 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BACE1 mRNA CTD PMID:16483693 arsane increases activity EXP 6480464 Arsenic results in increased activity of BACE1 protein CTD PMID:29155576 arsane multiple interactions EXP 6480464 [Arsenic co-treated with Cadmium co-treated with Lead] promotes the reaction [BACE1 protein results in increased metabolism of APP protein] CTD PMID:25288670 arsenic atom increases activity EXP 6480464 Arsenic results in increased activity of BACE1 protein CTD PMID:29155576 arsenic atom multiple interactions EXP 6480464 [Arsenic co-treated with Cadmium co-treated with Lead] promotes the reaction [BACE1 protein results in increased metabolism of APP protein] CTD PMID:25288670 arsenous acid decreases expression ISO RGD:1606566 6480464 Arsenic Trioxide results in decreased expression of BACE1 mRNA CTD PMID:22521957 azure B decreases activity ISO RGD:1606566 6480464 Azure B results in decreased activity of BACE1 protein CTD PMID:30500345 benzo[a]pyrene increases expression ISO RGD:1332039 6480464 Benzo(a)pyrene results in increased expression of BACE1 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1606566 6480464 7 more ... CTD PMID:26238291 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA CTD PMID:25607892 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BACE1 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BACE1 mRNA CTD PMID:36041667 bisphenol A decreases methylation ISO RGD:1606566 6480464 bisphenol A results in decreased methylation of BACE1 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BACE1 mRNA CTD PMID:29097150 more ... bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BACE1 mRNA CTD PMID:36041667 butanal decreases expression ISO RGD:1606566 6480464 butyraldehyde results in decreased expression of BACE1 mRNA CTD PMID:26079696 cadmium atom multiple interactions EXP 6480464 [Arsenic co-treated with Cadmium co-treated with Lead] promotes the reaction [BACE1 protein results in increased metabolism of APP protein] CTD PMID:25288670 cannabidiol decreases expression ISO RGD:1606566 6480464 Cannabidiol results in decreased expression of BACE1 mRNA CTD PMID:28025562 carbon nanotube increases expression ISO RGD:1332039 6480464 Nanotubes, Carbon results in increased expression of BACE1 mRNA CTD PMID:25620056 ceftriaxone decreases expression EXP 6480464 Ceftriaxone results in decreased expression of BACE1 mRNA CTD PMID:29745864 CGP 52608 multiple interactions ISO RGD:1606566 6480464 CGP 52608 promotes the reaction [RORA protein binds to BACE1 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:1332039 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BACE1 gene CTD PMID:20938992 chromium(6+) affects expression ISO RGD:1606566 6480464 chromium hexavalent ion affects the expression of BACE1 mRNA CTD PMID:30690063 clofibrate increases expression ISO RGD:1332039 6480464 Clofibrate results in increased expression of BACE1 mRNA CTD PMID:23811191 copper atom multiple interactions ISO RGD:1606566 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Copper results in increased expression of BACE1 mRNA] more ... CTD PMID:18583042 copper atom increases expression ISO RGD:1606566 6480464 Copper results in increased expression of BACE1 mRNA CTD PMID:18583042 copper(0) multiple interactions ISO RGD:1606566 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Copper results in increased expression of BACE1 mRNA] more ... CTD PMID:18583042 copper(0) increases expression ISO RGD:1606566 6480464 Copper results in increased expression of BACE1 mRNA CTD PMID:18583042 copper(II) chloride increases expression EXP 6480464 cupric chloride results in increased expression of BACE1 mRNA, cupric chloride results in increased expression of BACE1 protein CTD PMID:22542740 coumestrol multiple interactions ISO RGD:1606566 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE1 mRNA CTD PMID:19167446 curcumin multiple interactions ISO RGD:1606566 6480464 Curcumin inhibits the reaction [Copper results in increased expression of BACE1 mRNA], Curcumin inhibits the reaction [Hydrogen Peroxide results in increased expression of BACE1 mRNA] CTD PMID:18583042 , PMID:31521693 curcumin increases expression ISO RGD:1606566 6480464 Curcumin results in increased expression of BACE1 mRNA CTD PMID:31521693 cyclosporin A decreases expression ISO RGD:1606566 6480464 Cyclosporine results in decreased expression of BACE1 mRNA CTD PMID:20106945 cyprodinil multiple interactions ISO RGD:1332039 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of BACE1 protein CTD PMID:31939705 DDE multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA CTD PMID:25607892 DDT increases expression ISO RGD:1606566 6480464 DDT results in increased expression of BACE1 CTD PMID:25720399 dexamethasone multiple interactions EXP 6480464 [APP protein alternative form co-treated with Dexamethasone] results in increased expression of BACE1 mRNA more ... CTD PMID:22484447 diarsenic trioxide decreases expression ISO RGD:1606566 6480464 Arsenic Trioxide results in decreased expression of BACE1 mRNA CTD PMID:22521957 dibutyl phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA CTD PMID:25607892 Didymin decreases activity ISO RGD:1606566 6480464 didymin results in decreased activity of BACE1 protein CTD PMID:31194956 Didymin multiple interactions ISO RGD:1606566 6480464 didymin inhibits the reaction [APP protein alternative form results in increased expression of BACE1 protein] CTD PMID:31194956 diethyldithiocarbamic acid multiple interactions ISO RGD:1606566 6480464 Ditiocarb inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BACE1 mRNA] CTD PMID:28242320 dinophysistoxin 1 decreases expression ISO RGD:1606566 6480464 dinophysistoxin 1 results in decreased expression of BACE1 mRNA CTD PMID:28939011 dioxygen multiple interactions ISO RGD:1606566 6480464 alpha-Tocopherol inhibits the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA] more ... CTD PMID:19196431 dioxygen increases expression ISO RGD:1606566 6480464 Oxygen deficiency results in increased expression of BACE1 mRNA, Oxygen deficiency results in increased expression of BACE1 protein CTD PMID:19196431 donepezil hydrochloride multiple interactions ISO RGD:1332039 6480464 Donepezil inhibits the reaction [Streptozocin results in increased expression of BACE1 protein] CTD PMID:30481507 dorsomorphin multiple interactions ISO RGD:1606566 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Enterolactone multiple interactions ISO RGD:1606566 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE1 mRNA CTD PMID:19167446 entinostat multiple interactions ISO RGD:1606566 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BACE1 mRNA CTD PMID:27188386 entinostat decreases expression ISO RGD:1606566 6480464 entinostat results in decreased expression of BACE1 mRNA CTD PMID:26272509 epoxiconazole multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA CTD PMID:25607892 ethanol affects splicing ISO RGD:1332039 6480464 Ethanol affects the splicing of BACE1 mRNA CTD PMID:30319688 fenthion decreases expression ISO RGD:1332039 6480464 Fenthion results in decreased expression of BACE1 mRNA CTD PMID:34813904 ferulic acid multiple interactions ISO RGD:1606566 6480464 ferulic acid inhibits the reaction [Copper results in increased expression of BACE1 mRNA] CTD PMID:18583042 folic acid multiple interactions ISO RGD:1332039 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 furan decreases expression EXP 6480464 furan results in decreased expression of BACE1 mRNA CTD PMID:25539665 genistein multiple interactions EXP 6480464 Genistein inhibits the reaction [aluminum chloride results in increased expression of BACE1 mRNA] CTD PMID:28552514 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of BACE mRNA, Gentamicins results in decreased expression of BACE1 mRNA CTD PMID:22061828 , PMID:33387578 ginsenoside Rg1 multiple interactions EXP 6480464 ginsenoside Rg1 inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in increased expression of BACE1 mRNA] CTD PMID:22484447 Goe 6976 multiple interactions ISO RGD:1606566 6480464 Go 6976 inhibits the reaction [Phorbol 12, 13-Dibutyrate affects the localization of BACE1 protein] CTD PMID:19476501 gold atom multiple interactions ISO RGD:1332039 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of BACE1 mRNA CTD PMID:19695318 gold(0) multiple interactions ISO RGD:1332039 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of BACE1 mRNA CTD PMID:19695318 hydrogen peroxide multiple interactions ISO RGD:1606566 6480464 4-((alpha-L-rhamnosyloxy)benzyl)isothiocyanate inhibits the reaction [Hydrogen Peroxide results in increased expression of BACE1 mRNA], Curcumin inhibits the reaction [Hydrogen Peroxide results in increased expression of BACE1 mRNA] CTD PMID:31521693 hydrogen peroxide increases expression ISO RGD:1606566 6480464 Hydrogen Peroxide results in increased expression of BACE1 mRNA CTD PMID:31521693 hypochlorous acid decreases expression ISO RGD:1332039 6480464 Hypochlorous Acid results in decreased expression of BACE1 mRNA CTD PMID:19376150 ibuprofen multiple interactions ISO RGD:1606566 6480464 GW0072 inhibits the reaction [Ibuprofen inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of BACE1 mRNA]] more ... CTD PMID:14586007 ibuprofen decreases expression EXP 6480464 Ibuprofen results in decreased expression of BACE1 mRNA CTD PMID:16407166 ibuprofen decreases expression ISO RGD:1332039 6480464 Ibuprofen results in decreased expression of BACE1 mRNA CTD PMID:16407166 ibuprofen multiple interactions ISO RGD:1332039 6480464 GW0072 inhibits the reaction [Ibuprofen results in decreased expression of BACE1 mRNA] CTD PMID:16407166 ibuprofen decreases expression ISO RGD:1606566 6480464 Ibuprofen results in decreased expression of BACE1 mRNA CTD PMID:14586007 ibuprofen decreases activity ISO RGD:1606566 6480464 Ibuprofen results in decreased activity of BACE1 protein CTD PMID:14586007 icariin multiple interactions EXP 6480464 icariin inhibits the reaction [APP protein alternative form results in increased expression of BACE1 mRNA] CTD PMID:19782061 indometacin decreases expression ISO RGD:1332039 6480464 Indomethacin results in decreased expression of BACE1 mRNA CTD PMID:16407166 indometacin multiple interactions ISO RGD:1606566 6480464 GW0072 inhibits the reaction [Indomethacin inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of BACE1 mRNA]] CTD PMID:14586007 isoflurane increases expression ISO RGD:1606566 6480464 Isoflurane results in increased expression of BACE1 protein CTD PMID:17287498 ketamine increases expression ISO RGD:1332039 6480464 Ketamine results in increased expression of BACE1 protein CTD PMID:35378374 ketamine multiple interactions ISO RGD:1606566 6480464 Ketamine results in increased expression of and affects the localization of BACE1 protein, Monensin inhibits the reaction [Ketamine results in increased expression of and affects the localization of BACE1 protein] CTD PMID:35378374 L-methionine multiple interactions ISO RGD:1332039 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BACE1 gene CTD PMID:20938992 lead diacetate increases expression ISO RGD:1332039 6480464 lead acetate results in increased expression of BACE1 mRNA, lead acetate results in increased expression of BACE1 protein CTD PMID:23867794 lead diacetate multiple interactions ISO RGD:1332039 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of BACE1 mRNA, [lead acetate results in increased abundance of Lead] which results in increased expression of BACE1 protein CTD PMID:31730887 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of BACE1 protein CTD PMID:29908845 lead diacetate multiple interactions ISO RGD:1606566 6480464 [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in increased expression of BACE1 protein] more ... CTD PMID:31843630 lead(0) increases expression ISO RGD:1606566 6480464 Lead results in increased expression of BACE1 protein CTD PMID:22272629 lead(0) increases expression ISO RGD:1332039 6480464 Lead results in increased expression of BACE1 mRNA, Lead results in increased expression of BACE1 protein CTD PMID:35426476 lead(0) multiple interactions ISO RGD:1332039 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of BACE1 mRNA, [lead acetate results in increased abundance of Lead] which results in increased expression of BACE1 protein CTD PMID:31730887 lead(0) multiple interactions ISO RGD:1606566 6480464 [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in increased expression of BACE1 protein] more ... CTD PMID:31843630 , PMID:35426476 lead(0) multiple interactions EXP 6480464 [Arsenic co-treated with Cadmium co-treated with Lead] promotes the reaction [BACE1 protein results in increased metabolism of APP protein] CTD PMID:25288670 lead(2+) increases expression ISO RGD:1606566 6480464 Lead results in increased expression of BACE1 protein CTD PMID:22272629 lead(2+) increases expression ISO RGD:1332039 6480464 Lead results in increased expression of BACE1 mRNA, Lead results in increased expression of BACE1 protein CTD PMID:35426476 lead(2+) multiple interactions ISO RGD:1332039 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of BACE1 mRNA, [lead acetate results in increased abundance of Lead] which results in increased expression of BACE1 protein CTD PMID:31730887 lead(2+) multiple interactions EXP 6480464 [Arsenic co-treated with Cadmium co-treated with Lead] promotes the reaction [BACE1 protein results in increased metabolism of APP protein] CTD PMID:25288670 lead(2+) multiple interactions ISO RGD:1606566 6480464 [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in increased expression of BACE1 protein] more ... CTD PMID:31843630 , PMID:35426476 linuron multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA CTD PMID:25607892 lipopolysaccharide multiple interactions ISO RGD:1606566 6480464 [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BACE1 mRNA more ... CTD PMID:28242320 lovastatin multiple interactions ISO RGD:1606566 6480464 [Lovastatin co-treated with APP protein] results in decreased expression of BACE1 protein CTD PMID:29341888 lovastatin decreases expression EXP 6480464 Lovastatin results in decreased expression of BACE1 protein CTD PMID:29341888 manganese atom increases expression ISO RGD:1606566 6480464 Manganese results in increased expression of BACE1 mRNA CTD PMID:18583042 manganese(0) increases expression ISO RGD:1606566 6480464 Manganese results in increased expression of BACE1 mRNA CTD PMID:18583042 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Aluminum Chloride results in increased expression of BACE1 protein] CTD PMID:33130240 mepanipyrim multiple interactions ISO RGD:1332039 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of BACE1 protein CTD PMID:31939705 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of BACE1 protein CTD PMID:30367931 methylmercury chloride decreases expression ISO RGD:1606566 6480464 methylmercuric chloride results in decreased expression of BACE1 mRNA CTD PMID:24118919 , PMID:28001369 minocycline multiple interactions ISO RGD:1606566 6480464 Minocycline inhibits the reaction [Copper results in increased expression of BACE1 mRNA] CTD PMID:18583042 monensin A multiple interactions ISO RGD:1606566 6480464 Monensin inhibits the reaction [Ketamine results in increased expression of and affects the localization of BACE1 protein] CTD PMID:35378374 naproxen decreases expression ISO RGD:1332039 6480464 Naproxen results in decreased expression of BACE1 mRNA CTD PMID:16407166 paracetamol increases expression ISO RGD:1606566 6480464 Acetaminophen results in increased expression of BACE1 mRNA CTD PMID:22230336 pentetrazol increases expression EXP 6480464 Pentylenetetrazole results in increased expression of BACE1 protein CTD PMID:32653415 pentetrazol multiple interactions EXP 6480464 Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of BACE1 protein] CTD PMID:32653415 phenobarbital affects expression ISO RGD:1332039 6480464 Phenobarbital affects the expression of BACE1 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1606566 6480464 Phenylmercuric Acetate results in increased expression of BACE1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1606566 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE1 mRNA CTD PMID:27188386 PhIP increases expression ISO RGD:1332039 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of BACE1 protein CTD PMID:32169473 phorbol 12,13-dibutanoate multiple interactions ISO RGD:1606566 6480464 Go 6976 inhibits the reaction [Phorbol 12, 13-Dibutyrate affects the localization of BACE1 protein] CTD PMID:19476501 phorbol 12,13-dibutanoate affects localization ISO RGD:1606566 6480464 Phorbol 12, 13-Dibutyrate affects the localization of BACE1 protein CTD PMID:19476501 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1606566 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [Trientine inhibits the reaction [S100B protein results in increased expression of BACE1 protein]] CTD PMID:23541064 pioglitazone multiple interactions ISO RGD:1606566 6480464 pioglitazone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of and results in increased activity of BACE1 protein] CTD PMID:14586007 pioglitazone decreases expression ISO RGD:1606566 6480464 pioglitazone results in decreased expression of BACE1 mRNA CTD PMID:14586007 pioglitazone decreases activity ISO RGD:1606566 6480464 pioglitazone results in decreased activity of BACE1 protein CTD PMID:14586007 pioglitazone decreases expression ISO RGD:1332039 6480464 pioglitazone results in decreased expression of BACE1 mRNA, pioglitazone results in decreased expression of BACE1 protein CTD PMID:15817521 , PMID:16407166 pirinixic acid multiple interactions ISO RGD:1332039 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of BACE1 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1332039 6480464 pirinixic acid results in increased expression of BACE1 mRNA CTD PMID:18301758 , PMID:23811191 potassium chromate increases expression ISO RGD:1606566 6480464 potassium chromate(VI) results in increased expression of BACE1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1606566 6480464 potassium chromate(VI) results in decreased expression of BACE1 mRNA CTD PMID:22714537 potassium chromate multiple interactions ISO RGD:1606566 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BACE1 mRNA CTD PMID:22079256 prochloraz multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA CTD PMID:25607892 procymidone multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA CTD PMID:25607892 propiconazole decreases expression ISO RGD:1332039 6480464 propiconazole results in decreased expression of BACE1 mRNA CTD PMID:21278054 pyrimethanil multiple interactions ISO RGD:1332039 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of BACE1 protein CTD PMID:31939705 quercetin decreases activity ISO RGD:1606566 6480464 Quercetin results in decreased activity of BACE1 protein CTD PMID:31194956 rotenone multiple interactions ISO RGD:1606566 6480464 Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA] CTD PMID:19196431 S-adenosyl-L-homocysteine increases expression ISO RGD:1332039 6480464 S-Adenosylhomocysteine results in increased expression of BACE1 protein CTD PMID:19635394 SB 203580 multiple interactions ISO RGD:1606566 6480464 SB 203580 inhibits the reaction [Copper results in increased expression of BACE1 mRNA] CTD PMID:18583042 SB 431542 multiple interactions ISO RGD:1606566 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sevoflurane increases expression ISO RGD:1332039 6480464 sevoflurane results in increased expression of BACE1 protein CTD PMID:19433662 sevoflurane multiple interactions EXP 6480464 Dietary Fats promotes the reaction [Sevoflurane results in increased expression of BACE1 protein] CTD PMID:35174938 sevoflurane increases expression EXP 6480464 Sevoflurane results in increased expression of BACE1 protein CTD PMID:35174938 sevoflurane increases expression ISO RGD:1606566 6480464 sevoflurane results in increased expression of BACE1 protein CTD PMID:19433662 silver atom decreases expression ISO RGD:1332039 6480464 Silver results in decreased expression of BACE1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1332039 6480464 Silver results in decreased expression of BACE1 mRNA CTD PMID:27131904 sodium arsenite increases expression ISO RGD:1606566 6480464 sodium arsenite results in increased expression of BACE1 mRNA CTD PMID:17879257 streptozocin multiple interactions ISO RGD:1332039 6480464 Alendronate inhibits the reaction [Streptozocin results in increased expression of BACE1 protein], Donepezil inhibits the reaction [Streptozocin results in increased expression of BACE1 protein] CTD PMID:30481507 streptozocin increases expression ISO RGD:1332039 6480464 Streptozocin results in increased expression of BACE1 protein CTD PMID:30481507 sunitinib increases expression ISO RGD:1606566 6480464 Sunitinib results in increased expression of BACE1 mRNA CTD PMID:31533062 thimerosal decreases expression ISO RGD:1606566 6480464 Thimerosal results in decreased expression of BACE1 mRNA CTD PMID:27188386 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of BACE1 mRNA CTD PMID:23411599 , PMID:34492290 tolfenamic acid decreases expression ISO RGD:1332039 6480464 tolfenamic acid results in decreased expression of BACE1 mRNA, tolfenamic acid results in decreased expression of BACE1 protein CTD PMID:24462621 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of BACE1 gene CTD PMID:27618143 troglitazone decreases expression ISO RGD:1332039 6480464 troglitazone results in decreased expression of BACE1 mRNA CTD PMID:28973697 uranium atom affects expression ISO RGD:1606566 6480464 Uranium affects the expression of BACE mRNA CTD PMID:15672453 valproic acid affects expression ISO RGD:1606566 6480464 Valproic Acid affects the expression of BACE1 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1606566 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BACE1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1606566 6480464 Valproic Acid results in increased expression of BACE1 mRNA CTD PMID:23179753 more ... vinclozolin multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA CTD PMID:25607892 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of BACE1 mRNA CTD PMID:19015723 vorinostat decreases expression ISO RGD:1606566 6480464 vorinostat results in decreased expression of BACE1 mRNA CTD PMID:27188386
